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Single-breath carbon monoxide diffusing capacity in the whole lung (DLCO) and per unit alveolar 
volume (DLCONA), as expressed in percentage of normal values, gave discordant results when 
VA of the patients was abnormal. It was hypothesized that normal reference values were 
inappropriate to interpret data collected in such patients. To substantiate this hypothesis, 
DLCO and DLCOIVA were measured in four groups: (1) normal volunteers in whom both 
indices were measured at five different VA; (2) patients with high VA; (3) emphysematous 
patients; and (4) patients with diffuse interstitial lung diseases (DILD). In normal subjects, 
DLCO increased and DLCONA decreased with VA. In patients with overinflated lungs, the 
percentage of DLCO was more increased than DLCOIVA. In the emphysematous patients, both 
indices were equally decreased. In patients with DILD, DLCO was significantly more decreased 
than DLCONA in those suffering from a restrictive pattern. Theoretical values were 
re-calculated taking into account their true VA and using the relationships observed between 
BLCO, DLCONA and VA. The divergences between DLCO and DLCOIVA were strongly 
minimized. Therefore, the authors suggest the need to correct theoretical formulas in the 
presence of a restrictive pattern. 
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Introduction 
The single-breath test using carbon monoxide is 
the most widely used method to measure the 
pulmonary diffusing capacity (1). The result is 
usually expressed for the whole lung (DLCO) 
or per unit alveolar volume (DLCOIVA) (1,2). 
Diffusion indices are generally lowered after 
lung surgery (l), in anaemia (l), in pulmonary 
emphysema (1) and in diffuse interstitial lung 
diseases (DILD) (1). 
As in a previous study (3) the present authors 
have frequently observed that in patients with 
a restrictive pattern of pulmonary function, 
DLCOIVA is proportionally less decreased than 
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DLCO. Conversely, the opposite trend has been 
observed in patients with an abnormally high 
alveolar volume (VA). Some authors have taken 
advantage of this discrepant evolution between 
DLCO and DLCONA to make some patho- 
physiological considerations. Thus, Ayers et al. 
(4) divided disease processes into those in which 
the DLCOIVA ratio was decreased; the former 
conditions were considered to be due primarily 
to loss of lung units, and among the latter 
conditions they listed emphysema, pulmonary 
vascular obstruction, anaemia and thickening of 
the alveolar capillary membrane. Ayers et al. (4) 
considered interstitial fibrosis to be an example 
of loss of lung units, leading to the maintenance 
of a normal DLCONA ratio, and gave alveolar 
proteinosis as a typical example for a thickened 
alveolar capillary membrane. Besides the thick- 
ening of the alveolar capillary membrane, 
destruction of the pulmonary vascular bed (e.g. 
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loss of surface area) also leads to a decrease 
in DLCONA; in fact, morphometric studies 
indicate that loss of surface area is the most 
important factor (5). 
The present paper proposes another explana- 
tion for the discordant variation for DLCO and 
DLCONA, when expressed in percentage of 
theoretical values, for interpreting data from 
patients with abnormal alveolar volume. In the 
authors’ opinion, formulas established from data 
collected in normal subjects holding their breath 
near total lung capacity (TLC) are inappropriate 
to interpret data of patients with abnormal VA. 
The purpose of the present work is not only to 
demonstrate this hypothesis, but also to correct 
predictive formulas established by the present 
authors (6) and other investigators (1,7,8). 
Therefore, four groups of subjects have been 
examined: normal volunteers; patients with 
abnormally high VA without pulmonary dis- 
eases; and patients suffering from lung emphy- 
sema and DILD. 
Subjects and Methods 
Four groups of subjects were investigated: (1) 23 
non-smoking healthy males, all members of the 
hospital staff, aged between 22 and 41 years and 
in whom DLCO was measured at five different 
lung volumes; (2) 23 patients with a TLC above 
normal limits, according to predicted values of 
Quanjer (9), with no respiratory problems and 
who were examined in the authors’ laboratory for 
a routine pre-operative evaluation; (3) 23 emphy- 
sematous patients, all smokers or exsmokers, 
with dyspnoea, an obstructive syndrome 
(FEV,NC ~80%) and DLCO below normal 
limits (10); and (4) 23 patients (13 males) with a 
diagnosis of DILD based on the usual criteria, 
including clinical history, radiographic abnor- 
malities, low DLCO, hypoxaemia on exercise 
and lung biopsies (in 18 patients). Three patients 
had Stage II or III sarcoidosis (with skin lesions, 
splenomegaly and peripheral lymph node en- 
largement), three patients had hypersensitivity 
pneumonitis (farmer’s lung or pigeon breeder’s 
lung), and 17 patients had interstitial fibrosis of 
unknown aetiology. In four of these 23 subjects, 
DLCO and DLCONA were also measured at 
different VAs as in the normal subjects. 
(a) (b) (e) 
FIG. 1. Pattern of the five inspiratory manoeuvres 
performed by 23 volunteers. TLC, total lung 
capacity; FRC, functional residual capacity; RV, 
residual volume. 
Spirometry was performed with a watersealed 
spirometer (Pulmonet III). Residual volume (RV) 
and functional residual capacity (FRC) were 
measured by the helium closed-circuit method. 
DLCO and DLCONA were estimated by the 
single-breath method, as modified in the authors’ 
laboratory (6). Measurements of single-breath 
diffusing capacity were performed with equip- 
ment that allows the selection of inspired volume 
(normally reaching 90% of TLC), washout vol- 
ume (normally 1 l), sampling volume (normally 
O-6 1) and apnoea time (normally 10 s) (11). The 
inspired gas mixture contained 0.3% CO and 
10% He in air. CO, CO,, He and 0, were 
analysed by infra-red analysers (Maihak, Unor 
2, for CO, Capnograph for COz), a katharo- 
meter (Collins) and a paramagnetic analyser 
(Servomex OAl50), respectively. All analysers 
underwent regular checks and calibrations with 
appropriate standard gas mixtures. Before any 
test run, the subjects rested, in a seated position, 
for 30 min in order to allow for the known 
decrease in DLCO during this period (12). 
Apnoea time was calculated according to Jones 
and Meade (13). Theoretical formulas for men 
were from Frans et al. (6) and for women from 
Salorinne (14). 
In the normal volunteers, five DLCO measure- 
ments were made according to the patterns 
described in Fig. 1 with inspiration of the test gas 
mixture from RV to about 90 [Fig. l(a)], 70 [Fig. 
1 (b)] or 50% [Fig. l(c)] of TLC, from mid- 
expiratory reserve volume to about 70% of TLC 
[Fig. l(d)] and from FRC to about 90% 
of TLC [Fig. l(e)]. The tests were separated by 
a IO-min interval and were carried out in a 
ALVEOLARVOLUME AND SINGLE-BREATH DLCO 265 
101 6:: 0.. l 
* . 
.* l 
. 
. 
. . 
. 
6' I I I I I I 
3 4 5 6 7 8 9 
VA (1) 
FIG. 2. Relationship between single-breath carbon 
monoxide diffusing capacity (DLCO) and alveolar 
volume (VA) in 23 volunteers. 
random sequence. Venous blood was sampled 
before and at the end of the experiments for 
measurements of carboxyhaemoglobin (HBCO) 
by means of a CIBA-CORNING 270 CO- 
Oximeter. The HBCO corresponding to each 
DLCO was calculated by interpolation, assuming 
a linear increase in HBCO with the duration of 
the experiment, and DLCO was corrected 
according to Forster et al. (15). 
Arterial blood gases were measured by appro- 
priate electrodes (CIBA-CORNING 278) at rest 
and during submaximal exercise on a Fleisch 
cycloergometer. Theoretical values for arterial 
blood gases during exercise were from Clerbaux 
et al. (16). 
STATISTICAL ANALYSIS 
Comparisons between DLCO and DLCONA, as 
expressed in percentage of theoretical values, 
were analysed by Student’s t-test for paired data. 
Relationships between DLCO, DLCOIVA and 
VA, arterial PO, during exercise and DLCO and 
DLCONA (in percentages) were determined by 
the least-squares method using a BMDP, New 
System Professional Edition, 1 .O statistical soft- 
ware, Statistical Solution@, Cork, Ireland. 
Results 
MEASUREMENTS IN NORMAL SUBJECTS 
In the 23 normal subjects, DLCO increased (Fig. 
2) and DLCOIVA decreased (Fig. 3) with 
increasing VA. Using the 115 available data 
points, the regressions of DLCO or DLCONA 
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FIG. 3. Relationship between alveolar volume (VA) 
and single-breath carbon monoxide diffusing capac- 
ity (DLCO) per unit alveolar volume (DLCOIVA) in 
23 volunteers. 
on VA (VA’) expressed in percentage of maximal 
VA, yielded the following equations: 
DLCO (o!) =64.2+0.358 (VA’) r=0*43 (1) 
DLCO/VA (%) 
= 365.5 - 5-l 59 (VA’) + 0.025 1 (VA’)2 
r=0.66 (2) 
Maximal VA values were based on the following 
equation derived from the data obtained in male 
subjects: 
VA (1)=7.436 (H) - 0.00054 (A) - 6.53 
(see = 0.602) (3) 
These equations are valid for VA between 42 and 
95% of maximal values, and on the prediction 
equation from Salorinne (14) for the female 
subjects: 
VA (1)=7.6 (H) - O-00982 (A) - 7.32 
(see = 0.507) (4) 
where H is height (in m) and A is age (in years). 
PATIENTS WITH DILD 
The data collected from patients with DILD are 
given in Table 1. In each patient, DLCO was 
below normal limits according to predicted val- 
ues (6,14). In the whole group, DLCO was 
percentually decreased more than DLCOIVA 
(45 f 14% vs. 63 f 180/o), whereas in the six 
patients without restriction, DLCO and 
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TABLE 1. Anthropometric data, spirometric indices, lung diffusing capacity for carbon 
monoxide, and arterial blood gases at rest and during submaximal exercise in 23 patients 
(12 males) with diffuse interstitial lung disease 
Percentage of 
predicted values 
Indices Mean SD Mean SD 
Age (years) 
Height (m) 
vc (1) 
FEV, (1) 
RV (1) 
TLC (I) 
DLCO 
(ml min - ’ torr - ‘) 
(mmol min - ’ kPa - ‘) 
DLCONA 
(mlmin-ltorr-ll-l) 
(mmolmin-” kPa-‘1-l 1 
PaO, 
(torr) R 
&Pa) 
(torr) E 
&Pa) 
PaCO, 
(torr) R 
(@‘a) 
(torr) E 
W-4 
H+ (nmol l- ‘) 
47.4 14.0 
I.72 0.08 
2.80 0.83 
2.04 0.53 
I.33 0.41 
4.13 1.07 
12.2 4.6 
4.09 1.54 
3.14 0.95 63 18 
l-05 0.32 - - 
64.5 10-9 
8.60 1.45 
52.5 10-o 
7.00 1.33 
37.2 4.1 
4.96 o-55 
35,5 4.1 
4.73 0.55 
37-7 2.9 
- 
- 
65 
64 
86 
70 
45 
82.5 
- 
84.0 
99-o 
- 
91.3 
- 
15 
13 
20 
14 
14 
- 
11 
- 
12 
- 
48 
- 
52 
- 
SD, standard deviation; VC, vital capacity; FEV,, forced expired volume in 1 s; RV, 
residual volume; TLC, total lung capacity; DLCO, single-breath diffusing capacity for 
carbon monoxide; DLCONA, single-breath diffusing capacity for carbon monoxide per 
unit alveolar volume; PaO,, arterial 0, tension; PaCO,, arterial CO, tension; H+, 
hydrogen ion concentration; R, rest; E, exercise. 
DLCONA were decreased to about the same 4.27 ml min - ’ torr - ’ 1 - ’ (1 a43 mmol min - ’ 
value (56 f 18% YS. 60 f 15%) (Fig. 4). kPa - ’ 1 - ‘) for DLCONA, corresponding to 61 
To verify the hypothesis that predicted values and 90% of conventional (6) predicted values, 
for DLCO and DLCONA are inappropriate in respectively. The measurement of both indices 
the presence of lung restriction due to DILD, new was made at a VA of 4.51 1, which is only 69% of 
predicted values for these indices were cal- a predicted VA of 6.53 1 using Equation 3. Using 
culated for each subject, taking into account, Equations 1 and 2 with a VA’ of 69%, predicted 
using Equations 1 and 2, that measurements values for DLCO and DLCONA for this subject 
were made at submaximal VA. The pro- became 26.8 ml min - r torr - ’ (8.98 mmol- 
cedure used can be illustrated by the fol- min- ’ kPa-‘) and 6~40mlmin-1torr-‘1-1 
lowing example: Patient PL, suffering from (2.14 mm01 min - * kPa - ’ 1 - ‘), respectively. 
sarcoidosis, aged 54 years and measuring Using these corrected predicted values, the pa- 
I.76 m, had values of 18.8 ml min - ’ torr - ’ tient’s DLCO and DLCONA became 70 and 67% 
(6.30 mmol min - ’ kPa- ‘) for DLCO and of predicted values, respectively. 
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FIG. 4. Carbon monoxide diffusing capacity 
(DLCO) and carbon monoxide diffusing capacity 
per unit alveolar volume (DLCONA) expressed as 
percentage of theoretical formulas in 23 patients 
with diffuse interstitial lung diseases when a 
restrictive pattern is present (a) or not (b). 
Adopting this procedure in all subjects 
resulted in mean values of 47.8 f 159% and 
43.6 f 14.6% for DLCO and DLCOIVA, respect- 
ively; values are now much closer to each other. 
To verify whether this novel way of expressing 
a reduction in diffusion indices was meaningful 
in terms of impairment of gas exchange, the 
relationship between arterial oxygen tension 
during exercise and the diffusion indices was 
calculated. The following results were obtained: 
PaO, (kPa)= 3.19+0.081 DLCO 
(% conv.) 
(torr)= 23*9+061 DLCO 
(% conv.) (r=0*54) 
(kPa)= 2.15+0*077 DLCONA 
(% conv.) 
(torr)= 16.1 +O-58 DLCONA 
(Oh conv.) (rz0.57) 
(kPa) = 3.07 + 0.077 DLCO 
(% corr.) 
(torr)= 23.0 + 0.58 DLCO 
(% corr.) (~~0.89) (Fig. 5) 
(kPa) = 2.85 + 0.087 DLCONA 
(% corr.) 
(torr)= 21.4+0.65 DLCOIVA 
(% corr.) (rz0.87) (Fig. 6) 
This shows that the correlation was substan- 
tially improved when DLCO and DLCOIVA 
were corrected so as to take into account the low 
VA at which measurements had been made. 
lor 
r = 0.89 n = 23 
0 10 20 30 40 50 60 70 80 
DLCO (%) 
FIG. 5. Relationship between arterial oxygen 
tension during exercise (PaO,) and carbon 
monoxide diffusing capacity (DLCO) expressed as 
percentage of predicted values, taking into account 
the alveolar volume of 23 patients with diffuse 
interstitial lung disease. 
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FIG. 6. Relationship between arterial oxygen 
tension during exercise (PaO,) and carbon 
monoxide diffusing capacity per unit alveolar 
volume (DLCOIVA) expressed as percentage of 
predicted values, taking into account the alveolar 
volume of 23 patients with diffuse interstitial lung 
diseases. 
In the four patients with DILD in whom 
indices were measured at different VAs, the 
slopes of the increase in DLCO as a function of 
VA were similar to the mean slope observed in 
the normal subjects (Fig. 7). 
PATIENTS WITH EMPHYSEMA 
Table 2 shows that in the patients with emphy- 
sema, in whom TLC was within normal limits, 
both DLCO and DLCOIVA were found to be 
equally decreased. 
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FIG. 7. Evolution of single-breath carbon monoxide 
diffusing capacity (DLCO) in function of alveolar 
volume in four patients with diffuse interstitial lung 
disease. 
PATIENTS WITH HIGH TLC 
Table 3 shows that in the group composed of 
patients without respiratory symptoms and with 
TLC above normal limits, DLCO was increased 
more than DLCONA. 
Discussion 
These data shall be discussed from two different 
points of view. First of all, the authors aim to 
demonstrate that classical formulas are inappro- 
priate to interpret data of patients with abnor- 
mal VAs. In a second step, a method will be 
proposed to correct theoretical formulas in func- 
tion of obtained VA, when a restrictive pattern is 
present. 
The discrepancy between DLCO and DLCO/ 
VA, when expressed in percentage of theoreti- 
cal formulas established from data collected in 
normal subjects holding their breath near TLC, 
is not due to the nature of their diseases but to 
the fact that these formulas were inappropriate 
to interpret data collected in patients with 
abnormally low or high VAs. Indeed, both 
DLCO and DLCONA were equally decreased 
in 23 emphysematous patients and in the six 
patients with DILD in whom VAs were within 
normal limits. On the contrary, the per- 
centage of DLCO was more decreased than 
DLCONA in the 17 patients with DILD in 
whom a restrictive pattern was observed. Con- 
versely, in 23 subjects with normal respiratory 
symptoms, examined pre-operatively, and in 
whom VA was higher than predicted, the per- 
centage of DLCO was more increased than 
DLCO. 
Three arguments are against the use of con- 
ventional prediction formula for DLCO in 
patients with restrictive lung disease. 
The first argument is of a physiological 
nature. The distribution of intrapulmonary flow 
distribution is more even at FRC than at TLC 
(17) and this distribution of perfusion is an 
important determinant of DLCO. Thus, it was 
shown that a nitrate-induced re-distribution of 
perfusion away from the uppermost lung parts 
led to a decrease in DLCO (18-20). On the 
other hand, the higher DLCO in non-smoking 
asthmatics is due to a better apical perfusion 
(21). DLCO is influenced by several kinds of 
maldistribution, including the distribution of 
DLCOIVA or diffusing capacity to perfusion 
(DLCOIQ) (22). In normal seated subjects, the 
DLCONA ratio increases from the apex to the 
base of the lung, and the DLCOIQ ratio 
decreases from the apex to the base (23,24). In 
the patients with DILD and a restrictive pat- 
tern, both RV and VC were decreased, which 
suggests a disappearance of pulmonary zones 
with extreme values of DLCOIVA and 
DLCOIQ. 
The second argument relates to anatomical 
considerations. It has been shown, in the rat 
lung, that at FRC, interalveolar septa are folded 
beneath the surface lining layers, thus leading to 
a partial or complete collapse of alveoli (25). As 
a consequence, some capillaries are shifted 
towards deep regions of the lung and, as they are 
no longer in contact with alveolar air, they are 
not involved in the diffusion of CO. During 
inhalation from FRC, some of the alveolar septa 
unfold and allow capillaries to take part in gas 
exchange. 
The last argument is that the relationship 
between arterial oxygen tension during exercise 
and diffusion indices at rest was considerably 
improved by using predictions taking into 
account the reduction in VA. These data do 
not show that the hypoxaemia in these subjects 
was due to diffusion limitation. However, 
Wagner et al. (26) and Agusti et al. (3) have 
recently shown that (A-a)DO, was partly due 
to diffusion limitation, not only during exercise, 
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TABLE 2. Anthropometric data, spirometric indices, lung diffusing capacity for carbon 
monoxide and arterial blood gases at rest and during submaximal exercise in 23 male 
patients with emphysema 
Percentage of 
predicted values 
Indices Mean SD Mean SD 
Age (years) 
Height (m) 
vc (1) 
FEV, (1) 
RV (1) 
TLC (1) 
DLCO 
(mlmin-‘torr-‘) 
(mmol min - ’ kPa ~ ‘) 
DLCOIVA 
(ml min-’ torr- ’ l- ‘) 
(mmolmin-’ kPaa’ 1-l) 
PaO, 
(torr) R 
(kPa) 
(torr) E 
&Pa) 
PaCO, 
(torr) R 
&Pa) 
(torr E) 
(kPa) 
H+ (nmol 1 - ‘) 
R 
E 
62.4 10.2 
1.72 0.08 
3.56 0.53 
1.54 0.6 
3.50 1.02 
7.06 0.94 
14.6 2.5 
4.89 0.84 
2.51 0.43 55 
0.84 0.14 - 
70.5 8.8 
9.40 1.17 
70.4 12.2 
9.39 1.63 
38.2 5.1 
5.09 0.68 
38.7 6.1 
5.16 0.81 
37.2 3.0 
39.2 3.2 
78 
47 
183 
107 
52 12 
81 
79 
101 
39 
- 
11 
17 
50 
18 
9 
12 
- 
11 
5 
- 
3 
SD, standard deviation; VC, vital capacity; FEV,, forced expired volume in 1 s; RV, 
residual volume; TLC, total lung capacity; DLCO, single-breath diffusing capacity for 
carbon monoxide; DLCOIVA, single-breath diffusing capacity for carbon monoxide per 
unit alveolar volume; PaO,, arterial 0, tension; PaCO,, arterial CO, tension; H+, 
hydrogen ion concentration; R, rest; E, exercise. 
but also at rest. Several authors have observed 
correlations between the diffusion indices and 
(A-a)DO,. Thus, Risk et al. (27) found that in 
patients with sarcoidosis, desquamative intersti- 
tial pneumonia, usual interstitial pneumonia, 
beryllium lung disease and asbestosis, increases 
in (A-a)DO, were best predicted by DLCO. 
Similarly, Owens et al. (28) have observed a 
significant relationship between the decrease in 
DLCO and the degree of oxygen desaturation 
during exercise in patients with pulmonary 
emphysema. 
The relationship between DLCO and VA has 
been studied by many authors. DLCO seems to be 
independent of VA when it is measured during 
expiration. This has been observed when radio- 
active CO’* was measured continuously through- 
out expiration (29), and when mouth samples 
were collected at different moments of expiration 
(13,30). More recently, Newth et al. (31) calcu- 
lated DLCO, the pulmonary capillary blood vol- 
ume (Vc) and the diffusing capacity of the 
membrane (DMCO) from expired concentrations 
of CO and He, at rest and during exercise. These 
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TABLE 3. Anthropometric data, spirometric indices and lung diffusing capacity in 23 
patients with a higher than normal total lung capacity 
Percentage of 
predicted values 
Indices Mean SD Mean SD 
Age (years) 40 9 - - 
Height (m) 1.76 0.08 - - 
vc (1) 6.95 0.68 129 13 
FEV, (1) 4.59 0.72 110 16 
RV (1) 2.47 1.32 145 17 
TLC (1) 9.42 1.04 140 12 
DLCO 
(ml min - ’ torr - ‘) 38.6 3.8 128 13 
(mmol min - ’ kPa - ‘) 12.9 1.3 
DLCONA 
(mlmin-ltorr-ll-l) 5.72 0.60 110 12 
(mmolmin-lkPa-ll-l 1 1.92 0.20 
SD, standard deviation; VC, vital capacity; FEV,, forced expired volume in 1 s; RV, 
residual volume; TLC, total lung capacity; DLCO, single-breath diffusing capacity for 
carbon monoxide; DLCONA, single-breath diffusing capacity for carbon monoxide per 
unit alveolar volume. 
three indices did not change while VA decreased. 
Similarly, Cassidy et al. (32) found that, at sub- 
maximal alveolar volume, DLCO was greater 
when VA was reached by exhaling the test gas 
mixture from TLC rather than by inspiring it 
from RV. They explained their data by a hyster- 
esis of the alveolar capillary membrane, which 
was confirmed by the present authors’ group (33). 
On the other hand, several authors have 
shown that DLCO and DLCONA are influenced 
by VA when the test gas mixture is inhaled from 
FRC to TLC (30,34-39). DLCO increased and 
DLCONA decreased when VA increased (Figs 2 
and 3). 
Functional studies have indicated that these 
changes in DLCO are due to changes in DMCO, 
and not to variations in Vc (38,40). Thus, the 
decrease in DLCO with increasing VA could be 
explained by a progressive thinning of the mem- 
brane. Anatomical data are in accordance with 
this assumption; in rapidly frozen cat lung, a 
doubling of pulmonary volume increases the 
alveolar surface area by 70% (41), and the same 
trend was observed in the dog (42). 
THE RATIONALE FOR THE INTRODUCTION 
OF DLCO/VA IN CLINICAL PRACTICE 
DLCONA was introduced in clinical practice 
mainly to allow for reductions in VA brought 
about by a loss of pulmonary tissue as, 
for example, following pneumonectomy. Thus, 
Englert (30) showed, in 74 patients, that pneu- 
monectomy resulted in a reduction of TLC to 
58% of predicted with DLCO and DLCONA 
being 70 and 114% of predicted, respectively. It 
is clear that in such instances, a ‘correction’ for 
DLCO by the subject’s VA is warranted, since 
the decrease in DLCO following pneumonec- 
tomy is of a totally different nature than that 
caused by a thickened alveolar capillary mem- 
brane, as in lung fibrosis, or by lung destruction, 
as in emphysema. However, such simple correc- 
tion of DLCO by VA may not be appropriate in 
all circumstances. Therefore, as argued here- 
after, it is proposed that prediction formulae for 
DLCONA, which have been established from 
data in normal subjects holding their breath near 
TLC, are inadequate to interpret DLCOIVA in 
patients with restrictive lung disease. 
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TABLE 4. Use of correction formulas on the theoretical values for DLCO and DLCOIVA in presence of a 
restrictive pattern 
Indices 
Frans et al. Miller et al. Crap0 et al. Cotes et ul. 
(6) (8) (7) (1) 
Predicted DLCO 
(ml min - ’ torr - ‘) 
(mmol min - ’ kPa - ‘) 
Predicted DLCOIVA 
(mlmin’torr ’ 1-l) 
(mmolmin-‘kPa-’ 1-l) 
VA (1) 
Obtained DLCO (% predicted) 
Obtained DLCONA (“! predicted 
VA (% predicted) 
Corrected theoretical values DLCO 
(mlmin-‘torr-‘) 
(mmol min - ’ kPa - ‘) 
Corrected theoretical value for DLCOIVA 
(mlmin~’ torr-’ 1-l) 
(mmolmin~’ kPa-’ 1-l) 
Observed DLCO in percent of corrected 
theoretical values 
Observed DLCOIVA in function corrected 
theoretical values 
30.8 29.5 35.0 28.8 
IO.32 9.88 11.73 9.65 
4.75 3.94 5.19 4.47 
1.59 1.32 1.74 1.50 
6.49 7.48 6.75 6.45 
61 64 54 65 
90 108 82 96 
66 57 63 66 
27.0 25.0 30.4 25.3 
8.98 8.54 10.18 8.41 
6.38 6.02 7.27 6.00 
2.14 2.02 2.43 2.01 
70 75 62 74 
67 71 59 71 
A patient with diffuse interstitial lung disease, having 18.8 ml min - ’ torr- ’ for DLCO and 
4.27mlmin’ torr-’ 1-l for DLVA was 4.51 1 torr - ’ (6.30 mmol min - ’ kPa - ‘) DLCONA 
(1.43 mmol min - ’ kPa - ’ 1 - ‘). 
METHOD OF CORRECTION DLCO AND 
DLCO/VA IN PRESENCE OF AN ABNORMAL VA 
From a clinical point of view, it seems unneces- 
sary to correct diffusion data collected in patients 
with an abnormally high VA. In contrast, it 
seems of clinical relevance to correct data ob- 
tained in patients with a restrictive pattern. This 
correction may be made by inserting VA in the 
theoretical formula for DLCO, as done by 
Gaensler and Smith (39). Alternatively, theoreti- 
cal values as published by several authors (1,6-8) 
may be corrected, as in the present authors’ 
patient. The results are relatively concordant 
(Table 4). 
In summary, it is suggested that predictive 
formulae of diffusion indices to interpret results 
obtained in patients with a restrictive syndrome 
should be corrected. Alternatively, and more 
pragmatically, it may simply be sufficient to 
consider that in patients with restrictive lung 
disease, DLCO is underestimated and DLCOIVA 
is overestimated. 
Acknowledgements 
A. Frans benefited from a ‘crkdit personnel aux 
chercheurs’. Mrs. Sandrine Simon typed the 
manuscript. 
References 
1. Cotes JE. Lung Function. Assessment 
cation in Medicine, 4th edn. Oxford: 
1979; p. 605. 
und Appli- 
Blackwell, 
2. Ogilvie CM, Forster RE, Blakemore WS, 
Morton JW. A standardized breath holding tech- 
nique for the clinical measurement of diffusing 
capacity of the lung for carbon monoxide. J Clin 
Invest 1957; 36: 1-17. 
272 A. FRANS ET AL 
3. Agusti AGN, Rota J, Dea J, Wagner PD, 
Xaubet A, Rodriguez-Roisin R. Mechanisms of 
gas exchange impairment in idiopathic pulmo- 
nary fibrosis. Am Rev Pulm Dis 1991; 143: 219- 
225. 
4. Ayers LN, Gunsberg ML, Fein J. Diffusing 
capacity, specific diffusing capacity and interpret- 
ation of diffusion defects. West J Med 1975; 123: 
255-264. 
5. Weibel ER. A simplified morphometric method 
for estimating diffusing capacity in normal and 
emphysematous human lungs. Am Rev Respir Dis 
1973; 107: 578-588. 
6. Frans A, Stanescu DC, Veriter C, Clerbaux Th, 
Brasseur L. Smoking and pulmonary diffusing 
capacity. Stand J Respir Dis 1975; 56: 165-183. 
7. Crapo RO, Morris AH. Standardized single 
breath normal values for carbon monoxide dif- 
fusing capacity. Am Rev Respir Dis 1981; 123: 
185-189. 
8. Miller A, Thurnton JC, Warshaw R, Anderson 
H, Teirstein A, Selikoff IJ. Single breath diffusing 
capacity in a representative sample of the popu- 
lation of Michigan, a large industrial state. Am 
Rev Respir Dis 1983; 127: 270-277. 
9. Quanjer Ph, Tammeling GJ, Cotes JE, Pedersen 
OF, Peslin R, Yernault JC. Lung volumes and 
forced ventilatory flows. Eur Respir J 1993; 6 
(Suppl. 16): 540. 
10. American Thoracic Society Committee on Diag- 
nostic Standards. Definition and classification of 
chronic bronchitis, asthma and pulmonary 
emphysema. Am Rev Respir Dis 1987; 136: 225- 
244. 
11. Fesler R, Frans A, Veriter C, Brasseur L. Circuit 
semi-automatique pour la mesure de la capacite 
de diffusion par la mtthode en apnee. Bull Europ 
Physio-Path01 Respir 1968; 4: 553-565. 
12. Billiet L. De Bepaling van de Pulmonaire Dtjiisie 
Capaciteit Door Enkelvoudige Inspiratie van 
Koolstof-monoxide en de Toepassing Ervan bij 
Longtuverculose en Silicose. Brussels: Arscia, 
1965; 421 pp. 
13. Jones RS, Meade F. A theoretical and exper- 
imental analysis of anomalies in the estimation of 
pulmonary diffusing capacity by the single breath 
method. Quart J Exptl Physioll961; 46: 131-143. 
14. Salorinne Y. Single-breath pulmonary diffusing 
capacity. Stand J Resp Dis 1976; 96 (Suppl.): 84. 
15. Forster RE, Fowler WS, Bates DV, Van Lingen 
B. The absorption of carbon monoxide by the 
lungs during breath holding. J Clin Invest 1954; 
33: 1135-l 145. 
16. Clerbaux Th, Nullens W, Veriter C, Frans A. 
Pulmonary gas exchange during graded exercise 
in normal, sedentary, non-smoking subjects. 
Path01 Biol 1989; 37: 1079-1084. 
17. Hughes JMB, Glazier JB, Maloney JE, West JB. 
Effect of lung volume on the distribution of 
pulmonary blood flow in man. Resp Physioll968; 
4: 58-72. 
18. Nemery B, Vanderlinden-Mahieu S, Piret L, 
Brasseur L, Frans A. Effect of nitroglycerin on 
pulmonary perfusion distribution and gas 
exchange of normal subjects. Eur J Clin Invest 
1982; 12: 177-184. 
19. Nemery B, Piret L, Brasseur L, Frans A. Effect of 
nitroglycerin on the pulmonary diffusing capacity 
of normal subjects at rest and during exercise. 
J Appl Physiol: Respirat Environ Exercise Physiol 
1982; 52: 851-856. 
20. Mwepu AK, Lebecque P, Piret L, Lampert E, 
Frans A. Effect of molsidomine on the lung 
diffusing capacity of normal men. Path01 Biol 
1988; 36: 197-201. 
21. Collard Ph, Nijan B, Nejadnik B, Keyeux A, 
Frans A. Single breath diffusing capacity for 
carbon monoxide in stable asthma. Chest 1994; 
105: 1426-1429. 
22. Piiper J, Sikand R. Determination of Dco by the 
single breath method in inhomogeneous lungs: 
theory. Resp Physiol 1966; 1: 75-87. 
23. Johnson RL Jr, Miller JM. Distribution of ven- 
tilation, blood flow and gas transfer coefficients 
in the lung. J Appl Physiol 1968; 25: l-15. 
24. Michaelson ED, Sackner MA, Johnson RL Jr. 
Vertical distributions of pulmonary diffusing 
capacity and capillary blood flow in man. J Clin 
Invest 1973; 52: 359-369. 
25. Weibel ER, Untersee P, Gil J, Zulaur M. Mor- 
phometric estimation of pulmonary diffusing 
capacity. VI. Effect of varying positive pressure 
inflation of air spaces. Respir Physiol 1973; 18: 
285-308. 
26. Wagner PD, Dantzker DR, Dueck R, de Polo 
JL, Wasserman K, West JB. Distribution of 
ventilation-perfusion ratios in patients with 
interstitial lung disease. Chest 1976; 69: 256- 
257. 
27. Risk C, Epler GR, Gaensler EA. Exercise 
alveolar-arterial oxygen pressure difference in 
interstitial lung disease. Chest 1984; 85: 69-73. 
28. Owens GR, Rogers RM, Pennock BE, Levin Q. 
The diffusing capacity as a predictor of arterial 
oxygen desaturation during exercise in patients 
with chronic obstructive pulmonary disease. 
N Engl J A4ed 1984; 310: 1218-1221. 
29. Wagner PD, Mazzone RW, West JB. Diffusing 
capacity and anatomic dead space for carbon 
monoxide. J Appl Physiol 1971; 31: 847-852. 
ALVEOLARVOLUME AND SINGLE-BREATH DLCO 273 
30. Englert M. Le Reseau Capillaire Pulmonaire chez 
I’Homme. Etude Physiopathologique. Masson, 
1967; p. 235. 
31. Newth CJL, Cotton DJ, Nadel JA. Pulmonary 
diffusing capacity measured at multiple intervals 
during a single exhalation in man. J Appl Physiol 
Respirat Environ Exercise Physiol 1997; 43: 617- 
625. 
32. Cassidy SS, Ramanathan M, Rose GL, Johnson 
RL Jr. Hysteresis in the relation between diffus- 
ing capacity of the lung and lung volume. J Appl 
Phyiol Respirat Environ Exercise Physiol 1980; 
49: 566-570. 
33. Lebecque P, Mwepu A, Veriter C, Rodenstein D, 
Nemery B, Frans A. Hysteresis of the alveolar 
capillary membrane in normal subjects. J Appl 
Physiol 1986; 60: 1442-1445. 
34. Marks A, Cugell DW, Cardigan JB, Gaensler 
EA. Clinical determination of diffusing capacity 
of the lungs. Am J Med 1957; 22: 51-73. 
35. Mittman C, Burrows B. Uniformity of pulmo- 
nary diffusion: effects of lung volume. J Appl 
Physiol 1959; 14: 496498. 
36. Cad&an JB, Marks A, Ellicott MF et al. An 
analysis of factors affecting the measurement of 
pulmonary diffusing capacity by the single breath 
method. J Clin Invest 1961; 40: 1495-1514. 
37. Hamer NAJ. Variations in the components of the 
diffusing capacity as the lung expands. Clin Sci 
1963; 24: 275-285. 
38. Gurtner Gh, Fowler WS. Interrelationships of 
factors affecting pulmonary diffusing capacity. 
J Appl Physiol 1971; 30: 619-624. 
39. Gaensler EA, Smith AA. Attachment for auto- 
mated single-breath diffusing capacity measure- 
ment. Chest 1973; 63: 136-145. 
40. Miller JM, Johnson RL Jr. Effect of lung infla- 
tion on pulmonary diffusing capacity at rest and 
exercise. J Clin Invest 1966; 45: 493-500. 
41. Staub NC, Storey WF. Relation between 
morphological and physiological events in lung 
studied by rapid freezing. J Appl Physiol 1962; 17: 
381-390. 
42. Dunnill MS. Effect of lung inflation on alveolar 
surface area in the dog. Nature 1967; 214: 1013- 
1014. 
